Cargando…

Integrated analysis of serum lipid profile for predicting clinical outcomes of patients with malignant biliary tumor

BACKGROUND: Serum lipids were reported to be the prognostic factors of various cancers, but their prognostic value in malignant biliary tumor (MBT) patients remains unclear. Thus we aim to assess and compare prognosis values of different serum lipids, and construct a novel prognostic nomogram based...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Lejia, Ji, Xin, Wang, Dongyue, Guan, Ai, Xiao, Yao, Xu, Haifeng, Du, Shunda, Xu, Yiyao, Zhao, Haitao, Lu, Xin, Sang, Xinting, Zhong, Shouxian, Yang, Huayu, Mao, Yilei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547451/ https://www.ncbi.nlm.nih.gov/pubmed/33036576 http://dx.doi.org/10.1186/s12885-020-07496-8

Ejemplares similares

Preoperative Immune Prognostic Index Can Predict the Clinical Outcomes of Patients with Gallbladder Cancer: Single-Center Experience
por: Sun, Lejia, et al.
Publicado: (2020)

Prognostic Value of the Albumin-to-γ-glutamyltransferase Ratio for Gallbladder Cancer Patients and Establishing a Nomogram for Overall Survival
por: Sun, Lejia, et al.
Publicado: (2021)

Comparison of the Prognostic Value of Platelet-Related Indices in Biliary Tract Cancer Undergoing Surgical Resection
por: Sun, Lejia, et al.
Publicado: (2021)

Controlling nutritional status score as a prognostic marker to predict overall survival in resected biliary tract cancers
por: Sun, Lejia, et al.
Publicado: (2021)

High Systemic Inflammation Response Index (SIRI) Indicates Poor Outcome in Gallbladder Cancer Patients with Surgical Resection: A Single Institution Experience in China
por: Sun, Lejia, et al.
Publicado: (2020)

The Impacts of Systemic Immune-Inflammation Index on Clinical Outcomes in Gallbladder Carcinoma
por: Sun, Lejia, et al.
Publicado: (2020)

Comprehensive analysis of coagulation indices for predicting survival in patients with biliary tract cancer
por: Ke, Xindi, et al.
Publicado: (2021)

Reassessment of different criteria for diagnosing post-hepatectomy liver failure: a single-center study of 1683 hepatectomy
por: Zheng, Yongchang, et al.
Publicado: (2017)

Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis
por: Sun, Lejia, et al.
Publicado: (2017)

Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure
por: Yang, Huayu, et al.
Publicado: (2021)

Albumin Binding Function: The Potential Earliest Indicator for Liver Function Damage
por: Ge, Penglei, et al.
Publicado: (2016)

Surgical Resection Improves the Outcome of the Patients With Neuroendocrine Tumor Liver Metastases: Large Data From Asia
por: Du, Shunda, et al.
Publicado: (2015)

Value of Quantitative and Qualitative Analyses of Circulating Cell-Free DNA as Diagnostic Tools for Hepatocellular Carcinoma: A Meta-Analysis
por: Liao, Wenjun, et al.
Publicado: (2015)

Differential Diagnosis of Immunoglobulin G4-associated Cholangitis From Cholangiocarcinoma
por: Du, Shunda, et al.
Publicado: (2016)

Application of associating liver partition and portal vein ligation for staged hepatectomy for hepatocellular carcinoma related to hepatitis B virus: comparison with traditional one-stage right hepatectomy
por: Zhang, Junwei, et al.
Publicado: (2020)

Management of intrahepatic recurrence after resection for hepatocellular carcinoma exceeding the barcelona clinic liver cancer criteria
por: Xu, Wei, et al.
Publicado: (2017)

The Prognostic Value of Systemic Inflammation Response Index in Cholangiocarcinoma Patients
por: Jin, Bao, et al.
Publicado: (2021)

Noninvasive detection of tumor-associated mutations from circulating cell-free DNA in hepatocellular carcinoma patients by targeted deep sequencing
por: Liao, Wenjun, et al.
Publicado: (2016)

The Clinicopathological and Prognostic Value of PD-L1 Expression in Cholangiocarcinoma: A Meta-Analysis
por: Xu, Gang, et al.
Publicado: (2019)

Time-restricted feeding causes irreversible metabolic disorders and gut microbiota shift in pediatric mice
por: Hu, Dandan, et al.
Publicado: (2018)

Multiple Primary Malignancies in Patients With Hepatocellular Carcinoma: A Largest Series With 26-Year Follow-Up
por: Xu, Wei, et al.
Publicado: (2016)

Aggressive Locoregional Treatment Improves the Outcome of Liver Metastases from Grade 3 Gastroenteropancreatic Neuroendocrine Tumors
por: Du, Shunda, et al.
Publicado: (2015)

Laparoscopic hepatectomy for patients who received enterostomy
por: Jin, Bao, et al.
Publicado: (2019)

Public Psychosocial and Behavioral Responses in the First Wave of COVID-19 Pandemic: A Large Survey in China
por: Yang, Huayu, et al.
Publicado: (2021)

Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2020)

Current trends and research topics regarding liver 3D bioprinting: A bibliometric analysis research
por: Jin, Bao, et al.
Publicado: (2022)

Alteration in gut microbiota caused by time‐restricted feeding alleviate hepatic ischaemia reperfusion injury in mice
por: Ren, Jinjun, et al.
Publicado: (2018)

Application and Progress of Cultured Models of Gallbladder Carcinoma
por: Xing, Jiali, et al.
Publicado: (2023)

In situ Detecting Lipids as Potential Biomarkers for the Diagnosis and Prognosis of Intrahepatic Cholangiocarcinoma
por: Li, Jiayi, et al.
Publicado: (2022)

Tea consumption and the risk of biliary tract cancer: a systematic review and dose–response meta-analysis of observational studies
por: Xiong, Jianping, et al.
Publicado: (2017)

Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract Carcinoma
por: Wang, Yunchao, et al.
Publicado: (2022)

Intratumoural microbiome can predict the prognosis of hepatocellular carcinoma after surgery
por: Sun, Lejia, et al.
Publicado: (2023)

Correlation Between PD-L2 Expression and Clinical Outcome in Solid Cancer Patients: A Meta-Analysis
por: Yang, Huayu, et al.
Publicado: (2019)

Patient-derived organoids: a promising model for personalized cancer treatment
por: Yang, Huayu, et al.
Publicado: (2018)

Prognostic Nomogram That Predicts Overall Survival of Patients with Distal Cholangiocarcinoma After Pancreatoduodenectomy
por: Chen, Qiao, et al.
Publicado: (2020)

Preoperative Bilirubin-Adjusted Carbohydrate Antigen 19-9 as a Prognostic Factor for Extrahepatic Cholangiocarcinoma Patients at a Single Center
por: Li, Jiayi, et al.
Publicado: (2020)

Application of a 3D Bioprinted Hepatocellular Carcinoma Cell Model in Antitumor Drug Research
por: Sun, Lejia, et al.
Publicado: (2020)

Diagnosis and treatment of a diaphragmatic pheochromocytoma: A case report
por: Wu, Xiangan, et al.
Publicado: (2020)

Association of a novel PKHD1 mutation in a family with autosomal dominant polycystic liver disease
por: Wang, Jiaru, et al.
Publicado: (2021)

Immune checkpoint inhibitor‐related molecular markers predict prognosis in extrahepatic cholangiocarcinoma
por: Jin, Bao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bv4oq7oom642qnlu7ridep8sns